CM

CME Group Inc.

CMEFinancial ServicesNASDAQ

Financial Data & Stock Exchanges · Last scanned Sep 8, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$6.52B
+6.4% YoY
Net Income
$4.07B
+15.5% YoY
EBITDA
$5.83B
+15.8% YoY
Free Cash Flow
$2.91B

Scan Results

Daily timeframe
6 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Sep 3 Above MA200+1.0% from MA200, price crossed above
Below MA1500.1% below MA150
Sep 2 RSI OverboughtRSI 79.1, above 70, stock may be overbought
About CME Group Inc.

Headquartered within the financial services sector, CME Group Inc. focuses on Financial Data & Stock Exchanges services and products. CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. The $101.15B market capitalization puts CME squarely in large-cap range for its industry. It offers futures and options products based on interest rates, equity indexes, and foreign exchange; and agricultural, energy, and metals commodities, as well as fixed income and foreign currency trading services.

Where CME stands vs its 150-day and 200-day moving averages

As of the September 3, 2026 close, CME finished 0.06% below its 150-day moving average ($277.93) and 0.98% above its 200-day moving average ($275.08). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is CME overbought or oversold?

At the September 3, 2026 close, CME's RSI(14) was 61.6, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$101.15B
P/E (TTM)23.86
Fwd P/E21.78
EPS$11.79
Beta0.28
52W Change+7.6%
Dividend Yield1.85%
ROE15.8%
Analysis

CME Group Inc. carries $3.87B in total debt against $2.28B in cash reserves — debt is roughly 1.7x the cash position. Managing this leverage effectively will be important for long-term financial stability. The company generates $2.91B in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at 15.8%, which is strong for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 1.5% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $5.02B (2022) to $6.52B (2025), reflecting a 30% increase over the period.

With a beta below 0.7, CME Group Inc. typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. No single metric tells the full story. Reviewing CME's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Financial Services stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms